Correlation Between Seres Therapeutics and CTi Biopharma
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and CTi Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and CTi Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and CTi Biopharma Corp, you can compare the effects of market volatilities on Seres Therapeutics and CTi Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of CTi Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and CTi Biopharma.
Diversification Opportunities for Seres Therapeutics and CTi Biopharma
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Seres and CTi is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and CTi Biopharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CTi Biopharma Corp and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with CTi Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CTi Biopharma Corp has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and CTi Biopharma go up and down completely randomly.
Pair Corralation between Seres Therapeutics and CTi Biopharma
If you would invest 58.00 in Seres Therapeutics on September 18, 2024 and sell it today you would earn a total of 31.00 from holding Seres Therapeutics or generate 53.45% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 5.0% |
Values | Daily Returns |
Seres Therapeutics vs. CTi Biopharma Corp
Performance |
Timeline |
Seres Therapeutics |
CTi Biopharma Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Seres Therapeutics and CTi Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Seres Therapeutics and CTi Biopharma
The main advantage of trading using opposite Seres Therapeutics and CTi Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, CTi Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CTi Biopharma will offset losses from the drop in CTi Biopharma's long position.Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
CTi Biopharma vs. Rigel Pharmaceuticals | CTi Biopharma vs. Fortress Biotech | CTi Biopharma vs. Reviva Pharmaceuticals Holdings | CTi Biopharma vs. Protalix Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |